Functional & Innovative Foods IPO

    Summary:

     

    Functional & Innovative Foods Limited operates an integrated food contract manufacturing business offering private label and full-service manufacturing across Ready-to-Eat, Ready-to-Cook, staples, sugar alternatives, spices and other allied FMCG products, alongside branded food products marketed through its subsidiary CQFIPL under the "Nallas" brand.

    The DRHP highlights key business risks, including dependence on private label and contract manufacturing customers, execution risk on the new manufacturing units being funded from the issue, reliance on subsidiary CQFIPL for branded product revenue, working capital intensity, and competition across the food processing and FMCG contract manufacturing space. Investors should refer to the DRHP and other publicly available information before making an investment decision.

     Functional & Innovative Foods IPO: Files DRHP for Fresh Issue

    India's food processing industry includes a large base of contract manufacturers that produce private-label goods for retail brands and FMCG companies, alongside operators that also sell under their own brand names. Functional & Innovative Foods Limited operates in both categories, running contract manufacturing for third-party brands and marketing its own branded products through a subsidiary.

    Functional & Innovative Foods Limited filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on June 30, 2026, for an initial public offering (IPO). The company manufactures Ready-to-Eat (RTE), Ready-to-Cook (RTC), staples, sugar alternatives, spices and other allied FMCG products, largely on a private label and full-service contract manufacturing basis for other businesses.

    The IPO comprises a fresh issue and an offer for sale, according to the DRHP. This article gives investors a plain summary of the company's operations, financial position, industry presence and business risks, based on the DRHP and publicly reported details.

    IPO Details

    The table below highlights the key details of the proposed public issue based on information available in the DRHP. Certain details such as the price band, lot size and issue dates are yet to be announced.

    ParticularsDetails
    IPO TypeBook Built Issue
    IPO Open DateTo be announced
    IPO Close DateTo be announced
    Face Value₹10 per equity share
    Price BandTo be announced
    Lot SizeTo be announced
    Fresh IssueUp to 60,00,000 equity shares
    Offer for SaleUp to 25,00,000 equity shares
    Listing ExchangeNSE and BSE

    The public issue comprises both a fresh issue and an offer for sale (OFS). The Fresh Issue is for up to 60,00,000 equity shares, and the company will receive these proceeds directly. The OFS comprises up to 25,00,000 equity shares being sold by existing shareholders.

    The final price band, issue dates and lot size are yet to be announced. The allocation across investor categories will be announced in the final offer documents subject to SEBI regulations. Not more than 50% of the net offer is reserved for QIBs, not less than 35% for retail investors, and not less than 15% for NIIs.

    About the Company

    Company Background

    Functional & Innovative Foods Limited traces its roots to Christy Friedgram Industry, founded in 1989 by T. S. Kumarasamy in Tiruchengode, Tamil Nadu, as the flagship enterprise of the Christy Group. The company's registered office remains in Tiruchengode, Namakkal district, Tamil Nadu. As of December 31, 2025, its product portfolio comprised more than 25 product offerings across more than 700 stock-keeping units (SKUs).

    Business Overview

    Functional & Innovative Foods operates as an integrated food contract manufacturing company serving businesses ranging from emerging brands to multinational FMCG companies.

    Its operations are organised around two areas:

    • Contract manufacturing, carried out through private label and full-service arrangements, covering end-to-end product development and manufacturing across Ready-to-Eat (RTE), Ready-to-Cook (RTC), staples, sugar alternatives, spices and other allied FMCG products, largely on a B2B basis for Indian and international customers

    • Branded products, manufactured and marketed through its wholly owned subsidiary, Christy Quality Foods (India) Private Limited (CQFIPL), under the flagship "Nallas" brand, distributed through an extensive network in Tamil Nadu

    The company's manufacturing operations run across four manufacturing units comprising nine facilities in Tamil Nadu, with automated systems across material handling, processing and packaging.

    Revenue Model

    Functional & Innovative Foods generates revenue primarily through private label and full-service contract manufacturing arrangements with businesses ranging from emerging brands to multinational FMCG companies.

    Its principal revenue streams include:

    • Ready-to-Eat (RTE) and Ready-to-Cook (RTC) products (47.80% of revenue)

    • Staples (23.50% of revenue)

    • Sugar alternatives (18.23% of revenue)

    • Spices (7.45% of revenue)

    • Other allied FMCG products (1.79% of revenue)

    • Packaging (0.36% of revenue)

    The company also earns revenue from branded food products sold under the "Nallas" brand through its subsidiary CQFIPL, distributed through an extensive network in Tamil Nadu.

    Industry Position

    Functional & Innovative Foods operates in India's food contract manufacturing segment, working with customers that range from emerging brands to multinational FMCG companies. Few listed peers in India combine private label contract manufacturing with an owned branded product line in the same manner, which limits direct listed-peer comparison in the DRHP.

    The company's four manufacturing units and nine facilities, along with in-house product development capability, position it as a supplier across several FMCG categories rather than a single-product manufacturer.

    Industry Overview

    India's food processing industry has expanded alongside rising demand for convenience foods, packaged staples and health-orientated products. FMCG companies and emerging brands increasingly rely on contract manufacturers to scale production without setting up their own facilities.

    Growth drivers for the contract food manufacturing segment include:

    • Rising demand for Ready-to-Eat and Ready-to-Cook products among urban consumers

    • FMCG companies outsourcing manufacturing to reduce capital investment

    • Growth in health-oriented categories such as sugar alternatives and functional foods

    • Expansion of organised retail and e-commerce distribution for packaged foods

    • Regulatory emphasis on food safety and quality certification favouring compliant manufacturers

    Contract manufacturers depend on the order volumes and category choices of the brands they serve. The DRHP data does not settle how customer concentration affects the company's manufacturing utilisation over time.

    Company Financials

    This section gives an overview of the business growth, profitability and balance sheet position of Functional & Innovative Foods based on financial performance reported in the DRHP. The table below summarises the key financial parameters on a restated consolidated basis.

    Financials (₹ crore) for period ended on31 March 202531 March 202431 March 2023
    Total Income260.76162.02115.57
    EBITDA34.4721.467.17
    Profit After Tax23.2213.763.22
    Total Assets98.4686.2958.45
    Net Worth27.5526.7212.94
    Total Borrowings34.4029.6422.77

    Strengths of Functional & Innovative Foods Limited

    Established contract manufacturing base

    Private label and full-service manufacturing capabilities with repeat customers across FMCG categories.

    Diversified product portfolio

    More than 25 product offerings across more than 700 SKUs spanning RTE, RTC, staples, sugar alternatives and spices.

    Integrated manufacturing infrastructure

    Four manufacturing units across nine facilities in Tamil Nadu with quality control and supply chain systems in place.

    Branded consumer presence

    The "Nallas" brand, marketed through subsidiary CQFIPL, gives the company revenue from its own branded products alongside contract manufacturing.

    Risks Associated with the Business

    Customer Concentration Risk

    Revenue from private label and contract manufacturing arrangements depends on order volumes from a limited set of brand customers.

    Capacity Expansion Risk

    Net Proceeds are earmarked for new units at Namakkal, Tamil Nadu, and Dhar, Madhya Pradesh. Execution delays or lower-than-planned utilisation would affect returns on this capital.

    Subsidiary Dependence

    Branded product revenue runs through subsidiary CQFIPL. Issue proceeds are also proposed for investment in CQFIPL to repay its borrowings.

    Working Capital Intensity

    The DRHP proposes utilising net proceeds toward long-term working capital requirements, which points to working-capital intensity in the underlying business.

    Competition Across Categories

    The company competes with other contract manufacturers and branded FMCG players across RTE, RTC, staples, spices and sugar alternatives at the same time.

    Geographic Concentration

    Manufacturing facilities are concentrated in Tamil Nadu, with the "Nallas" brand distribution network also concentrated in the state.

    Key Things Investors May Consider

    Before evaluating the IPO, investors may consider the following factors:

    • Revenue and profit growth across FY2024, FY2025 and the nine months ended December 2025

    • The mix of private label contract manufacturing versus branded "Nallas" product revenue

    • Customer concentration within the contract manufacturing business

    • Utilisation plans for the new Unit-V and Unit-VI capacity being funded from the issue

    • Planned use of Fresh Issue proceeds as stated in the DRHP, including debt repayment at the company and at CQFIPL

    • Working capital requirements relative to revenue growth

    • Competition from other food contract manufacturers and branded FMCG players

    • The size and sellers in the OFS portion of the issue

    Published Date : 28 Jul 2026

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    1 M+ Users

    icon-with-text

    4.8 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |